BMC Cancer (Mar 2024)
Correction: A real-world study of the effectiveness and safety of apatinib-based regimens in metastatic triple-negative breast cancer
- Weiwei Huang,
- Chenxi Wang,
- Yangkun Shen,
- Qi Chen,
- Zhijian Huang,
- Jian Liu,
- Xiaoyan Lin,
- Lili Wang,
- Fan Wu,
- Xinhua Chen,
- Nani Li,
- Yi Hong,
- Mulan Chen,
- Jieyu Li,
- Chuanzhong Huang
Affiliations
- Weiwei Huang
- Department of Medical Oncology, Fujian Medical University Union Hospital
- Chenxi Wang
- Fujian Key Laboratory of Innate Immune Biology, Biomedical Research Center of South China, Fujian Normal University Qishan Campus
- Yangkun Shen
- Fujian Key Laboratory of Innate Immune Biology, Biomedical Research Center of South China, Fujian Normal University Qishan Campus
- Qi Chen
- Fujian Key Laboratory of Innate Immune Biology, Biomedical Research Center of South China, Fujian Normal University Qishan Campus
- Zhijian Huang
- Department of Breast Surgical Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital
- Jian Liu
- Department of Medical Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital
- Xiaoyan Lin
- Department of Medical Oncology, Fujian Medical University Union Hospital
- Lili Wang
- Department of Medical Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital
- Fan Wu
- Department of Medical Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital
- Xinhua Chen
- Department of Medical Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital
- Nani Li
- Department of Medical Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital
- Yi Hong
- Department of Medical Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital
- Mulan Chen
- Department of Medical Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital
- Jieyu Li
- Laboratory of Immuno-Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital
- Chuanzhong Huang
- Laboratory of Immuno-Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital
- DOI
- https://doi.org/10.1186/s12885-024-12150-8
- Journal volume & issue
-
Vol. 24,
no. 1
pp. 1 – 1
Abstract
No abstracts available.
